NCT02621086View on ClinicalTrials.gov

Cellodextrin Tolerability Study

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

November 30, 2018

Study Completion Date

April 30, 2019

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

Cellodextrin

Gastrointestinal tolerability of single ascending doses of Cellodextrins

Trial Locations (1)

NG72UH

David Greenfield Human Physiology Unit, Nottingham

All Listed Sponsors
collaborator

Biotechnology and Biological Sciences Research Council

OTHER

lead

University of Nottingham

OTHER

NCT02621086 - Cellodextrin Tolerability Study | Biotech Hunter | Biotech Hunter